Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Aug 30;3(5):384-386.
doi: 10.1016/j.jdcr.2017.06.001. eCollection 2017 Sep.

Delayed-onset vemurafenib-induced panniculitis

Stephen L Vance  1 , Hannah M Singer  2 , David Silvers  3 , Sameera Husain  3 , Filamer Kabigting  1
Affiliations
Case Reports

Delayed-onset vemurafenib-induced panniculitis

Stephen L Vance et al. JAAD Case Rep. .
No abstract available

Keywords: BRAF inhibitor; drug reaction; panniculitis; vemurafenib.

PubMed Disclaimer

Figures

Fig 1
Fig 1
A, Erythematous tender subcutaneous nodules of the upper extremities with coalescence on the left upper arm. B, Discrete erythematous tender subcutaneous nodules of the bilateral lower legs.
Fig 2
Fig 2
A, Biopsy findings show a lobular neutrophilic panniculitis with an overlying lymphocytic infiltrate in the dermis. B, At higher power, a florid neutrophilic panniculitis is evident. (A and B, Hematoxylin-eosin stain; original magnifications: A, ×4; B, ×20.)
See this image and copyright information in PMC

References

    1. Davies H., Bignell G.R., Cox C. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949–954. - PubMed
    1. Boussemart L., Routier E., Mateus C. Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol. 2013;24(6):1691–1697. - PubMed
    1. Ferreira J., Toda-Brito H., Moura M.C., Sachse M.F., Costa-Rosa J. BRAFi-associated panniculitis - an emerging side effect with a variable histological picture: report of two cases and review of the literature. J Cutan Pathol. 2017;44(3):307–309. - PubMed
    1. Choy B., Chou S., Anforth R., Fernandez-Penas P. Panniculitis in patients treated with BRAF inhibitors: a case series. Am J Dermatopathol. 2014;36(6):493–497. - PubMed
    1. Vazquez-Osorio I., Sanchez-Aguilar M.D., Garcia-Rodino S., Suarez-Penaranda J.M., Aliste C., Vazquez-Veiga H. Vemurafenib-induced neutrophilic panniculitis: a new case and review of the literature. Am J Dermatopathol. 2016;38(7):e93–e96. - PubMed

Publication types

LinkOut - more resources